Local erythropoietin and endothelial progenitor cells improve regional cardiac function in acute myocardial infarction

BMC Cardiovascular Disorders

Volumn 10, Issue , 2010, Pages

  Stein, Andreas ^a   Knödler, Martina ^a   Makowski, Markus ^b   Kühnel, Sandra ^a   Nekolla, Stefan ^b   Keithahn, Alexandra ^b   Weidl, Eliane ^a   Groha, Philip ^a   Schürmann, Maren ^a   Saraste, Atti ^b   Botnar, Rene ^b   Oostendorp, Robert A J ^a   Ott, Ilka ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CD68 ANTIGEN; CHEMOKINE RECEPTOR CCR8; ERYTHROPOIETIN; MESSENGER RNA; OSTEOPONTIN; PROTEIN BAX; THROMBOCYTE FACTOR 4;

ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERIAL WALL THICKENING; ARTERY LIGATION; ARTICLE; BLOOD VESSEL PARAMETERS; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE WALL MOTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; IN VITRO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEUKOCYTE COUNT; NICK END LABELING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE RAT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STEM CELL TRANSPLANTATION; SYSTOLE; ANIMAL; CELL CULTURE; CELL PROLIFERATION; CONVALESCENCE; DISEASE MODEL; DRUG EFFECT; ENDOTHELIUM; HEART INFARCTION; HEART MUSCLE; INFLAMMATION; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; STEM CELL; TRANSPLANTATION;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIUM; ERYTHROPOIETIN; HUMANS; INFLAMMATION; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, NUDE; RECOVERY OF FUNCTION; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 77957703580     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-10-43     Document Type: Article

References (35)

1. Leone AM, Rutella S, Bonanno G, Abbate A, Rebuzzi AG, Giovannini S, Lombardi M, Galiuto L, Liuzzo G, Andreotti F, et al. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur Heart J 2005, 26(12):1196-1204. 10.1093/eurheartj/ehi164, 15734770.
2. Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, Rosso R, De Ferrari GM, Ferlini M, Goffredo L, Bertoletti A, et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005, 105(1):199-206. 10.1182/blood-2004-05-1831, 15345590.
3. Wojakowski W, Tendera M, Michalowska A, Majka M, Kucia M, Maslankiewicz K, Wyderka R, Ochala A, Ratajczak MZ. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 2004, 110(20):3213-3220. 10.1161/01.CIR.0000147609.39780.02, 15533859.
4. Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P, Salio M, Cerami A, Brines M. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci USA 2003, 100(8):4802-4806. 10.1073/pnas.0630444100, 153636, 12663857.
5. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001, 98(18):10344-10349. 10.1073/pnas.181177898, 56963, 11504914.
6. Ott I, Keller U, Knoedler M, Gotze KS, Doss K, Fischer P, Urlbauer K, Debus G, von Bubnoff N, Rudelius M, et al. Endothelial-like cells expanded from CD34+ blood cells improve left ventricular function after experimental myocardial infarction. Faseb J 2005, 19(8):992-994.
7. Dawn B, Bolli R. Adult bone marrow-derived cells: regenerative potential, plasticity, and tissue commitment. Basic Res Cardiol 2005, 100(6):494-503. 10.1007/s00395-005-0552-5, 16237509.
8. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, Zuba-Surma EK, Al-Mallah M, Dawn B. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007, 167(10):989-997. 10.1001/archinte.167.10.989, 17533201.
9. Belonje AM, Westenbrink BD, Voors AA, von Haehling S, Ponikowski P, Anker SD, van Veldhuisen DJ, Dickstein K. Erythropoietin levels in heart failure after an acute myocardial infarction: determinants, prognostic value, and the effects of captopril versus losartan. Am Heart J 2009, 157(1):91-96. 10.1016/j.ahj.2008.08.020, 19081402.
10. van der Meer P, Lipsic E, Henning RH, de Boer RA, Suurmeijer AJ, van Veldhuisen DJ, van Gilst WH. Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury. Eur J Heart Fail 2004, 6(7):853-859.
11. Sterin-Borda L, Barcelo AC, Bozzini CE. Erythropoietin improves cardiac contractility in post-hypoxic mice. Br J Haematol 2003, 121(1):180-186. 10.1046/j.1365-2141.2003.04239.x, 12670351.
12. Moon C, Krawczyk M, Ahn D, Ahmet I, Paik D, Lakatta EG, Talan MI. Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats. Proc Natl Acad Sci USA 2003, 100(20):11612-11617. 10.1073/pnas.1930406100, 208806, 14500913.
13. Maiese K, Li F, Chong ZZ. New avenues of exploration for erythropoietin. Jama 2005, 293(1):90-95. 10.1001/jama.293.1.90, 2254180, 15632341.
14. Katavetin P, Inagi R, Miyata T, Shao J, Sassa R, Adler S, Eto N, Kato H, Fujita T, Nangaku M. Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress. Biochem Biophys Res Commun 2007, 359(4):928-934. 10.1016/j.bbrc.2007.05.207, 17560935.
15. Anagnostou A, Liu Z, Steiner M, Chin K, Lee ES, Kessimian N, Noguchi CT. Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 1994, 91(9):3974-3978. 10.1073/pnas.91.9.3974, 43705, 8171022.
16. Masuda S, Nagao M, Takahata K, Konishi Y, Gallyas F, Tabira T, Sasaki R. Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. J Biol Chem 1993, 268(15):11208-11216.
17. Wu H, Lee SH, Gao J, Liu X, Iruela-Arispe ML. Inactivation of erythropoietin leads to defects in cardiac morphogenesis. Development 1999, 126(16):3597-3605.
18. Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O, Ihle JN. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 1993, 74(2):227-236. 10.1016/0092-8674(93)90414-L, 8343951.
19. Bao H, Jacobs-Helber SM, Lawson AE, Penta K, Wickrema A, Sawyer ST. Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells). Blood 1999, 93(11):3757-3773.
20. Ashley RA, Dubuque SH, Dvorak B, Woodward SS, Williams SK, Kling PJ. Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells. Pediatr Res 2002, 51(4):472-478. 10.1203/00006450-200204000-00012, 11919332.
21. Carlini RG, Reyes AA, Rothstein M. Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int 1995, 47(3):740-745. 10.1038/ki.1995.113, 7752572.
22. Sayan H, Ozacmak VH, Guven A, Aktas RG, Ozacmak ID. Erythropoietin stimulates wound healing and angiogenesis in mice. J Invest Surg 2006, 19(3):163-173. 10.1080/08941930600674694, 16809226.
23. Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, Urbich C, Mildner-Rihm C, Martin H, Zeiher AM, Dimmeler S. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 2003, 102(4):1340-1346. 10.1182/blood-2003-01-0223, 12702503.
24. Brunner S, Winogradow J, Huber BC, Zaruba MM, Fischer R, David R, Assmann G, Herbach N, Wanke R, Mueller-Hoecker J, et al. Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis. Faseb J 2009, 23(2):351-361. 10.1096/fj.08-109462, 18827024.
25. Ott I, Neumann FJ, Schomig A. Neutrophil hyper-reactivity after exercise-induced angina pectoris. Coron Artery Dis 1995, 6(7):525-532.
26. Li Y, Takemura G, Okada H, Miyata S, Maruyama R, Li L, Higuchi M, Minatoguchi S, Fujiwara T, Fujiwara H. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure. Cardiovasc Res 2006, 71(4):684-694. 10.1016/j.cardiores.2006.06.003, 16828072.
27. Zohlnhofer D, Ott I, Mehilli J, Schomig K, Michalk F, Ibrahim T, Meisetschlager G, von Wedel J, Bollwein H, Seyfarth M, et al. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. Jama 2006, 295(9):1003-1010. 10.1001/jama.295.9.1003, 16507801.
28. Mix TC, Brenner RM, Cooper ME, de Zeeuw D, Ivanovich P, Levey AS, McGill JB, McMurray JJ, Parfrey PS, Parving HH, et al. Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease. Am Heart J 2005, 149(3):408-413. 10.1016/j.ahj.2004.09.047, 15864229.
29. Katz O, Gil L, Lifshitz L, Prutchi-Sagiv S, Gassmann M, Mittelman M, Neumann D. Erythropoietin enhances immune responses in mice. Eur J Immunol 2007, 37(6):1584-1593. 10.1002/eji.200637025, 17458859.
30. Lifshitz L, Prutchi-Sagiv S, Avneon M, Gassmann M, Mittelman M, Neumann D. Non-erythroid activities of erythropoietin: Functional effects on murine dendritic cells. Mol Immunol 2009, 46(4):713-721. 10.1016/j.molimm.2008.10.004, 19027957.
31. Mittelman M, Neumann D, Peled A, Kanter P, Haran-Ghera N. Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models. Proc Natl Acad Sci USA 2001, 98(9):5181-5186. 10.1073/pnas.081275298, 33184, 11309490.
32. Prutchi Sagiv S, Lifshitz L, Orkin R, Mittelman M, Neumann D. Erythropoietin effects on dendritic cells: potential mediators in its function as an immunomodulator?. Exp Hematol 2008, 36(12):1682-1690. 10.1016/j.exphem.2008.07.010, 18922618.
33. Furlani D, Klopsch C, Gabel R, Ugurlucan M, Pittermann E, Klee D, Wagner K, Li W, Wang W, Ong LL, et al. Intracardiac erythropoietin injection reveals antiinflammatory potential and improved cardiac functions detected by Forced Swim Test. Transplant Proc 2008, 40(4):962-966. 10.1016/j.transproceed.2008.03.033, 18555090.
34. Gaebel R, Klopsch C, Furlani D, Yerebakan C, Li W, Ugurlucan M, Ma N, Steinhoff G. Single high-dose intramyocardial administration of erythropoietin promotes early intracardiac proliferation, proves safety and restores cardiac performance after myocardial infarction in rats. Interact Cardiovasc Thorac Surg 2009, 9(1):20-5. 10.1510/icvts.2008.191916, 19380336.
35. Klopsch C, Furlani D, Gabel R, Li W, Pittermann E, Ugurlucan M, Kundt G, Zingler C, Titze U, Wang W, et al. Intracardiac injection of erythropoietin induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model. J Cell Mol Med 2009, 13(4):664-679. 10.1111/j.1582-4934.2008.00546.x, 19449462.